Ropes & Gray took the lead among several firms in advising Pfizer on its decision Wednesday to pay $2.3 billion in fines and penalties to settle charges it illegally marketed several drugs for off-label uses and paid kickbacks to doctors, according to lawyers on the deal. The settlement is believed to be the largest health care fraud settlement in U.S. history, according to The Wall Street Journal and the U.S. Department of Justice.

About $1.3 billion of the total penalty goes toward resolving criminal charges that Pfizer illegally marketed the anti-inflammatory drug Bextra for off-label uses, according to the DOJ and the WSJ. A Pfizer subsidiary, Pharmacia & Upjohn Co., pleaded guilty to a felony count of violating federal laws on drug branding.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]